November 2011 Cough & Cold

AstraZeneca's Brilinta

November 09, 2011

Rx Product News Profile

The FDA approved Brilinta (ticagrelor) for reducing the rate of thrombotic cardiovascular events in patients with acute coronary syndrome when taken with aspirin.